Study on the stereoselectivity of racemic propranolol glucuronidation metabolism

马剑茵,邵青,栾连军,童国忠
DOI: https://doi.org/10.3321/j.issn:1001-2494.2004.03.017
2004-01-01
Abstract:OBJECTIVE: A HPLC method was developed to determine directly propranolol glucuronide in urine of healthy volunteers and evaluate the stereoselectivity of racemic propranolol glucuronidation metabolism. METHODS: The standard for this direct assay was prepared by incubation of liver microsomes with R-(+)-propranolol. The R-(+)-propranolol glucuronide [R-(+)-PG] obtained was purified and concentrated with solid-phase extraction. The stock concentration was measured, after enzymatic hydrolysis with β-glucuronidase, by an indirect method. The concentrations of R-(+) and S-(-)-propranolol glucuronide [S-(-)PG] in urine were determined and their pharmacokinetic parameters were calculated. RESULTS: The main pharmacokinetic parameters were as follow: K were (0.283 3 ± 0.058) and (0.194 6 ± 0.040) h-1, t max were (1.75 ± 0.33) and (2.21 ± 0.45) h, X u were (2.952 ± 0.615) and (5.648 ± 0.977) μmol for R-(+)-PG and S-(-)PG respectively. CONCLUSION: The glucuronidation of racemic propranolol in human has stereoselectivity.
What problem does this paper attempt to address?